Contraception and Hormone Replacement Therapy in Healthy Carriers of Germline BRCA1/2 Genes Pathogenic Variants: Results from an Italian Survey

SIMPLE SUMMARY: Being a healthy carrier of a BRCA1/2 pathogenetic variant is not a contraindication to hormonal contraception and menopause hormonal therapy; however, insufficient knowledge on the topic frequently translates into suboptimal counseling and care. The results of this nationwide Italian...

Descripción completa

Detalles Bibliográficos
Autores principales: Massarotti, Claudia, Buonomo, Barbara, Dellino, Miriam, Campanella, Maria, De Stefano, Cristofaro, Ferrari, Alberta, Anserini, Paola, Lambertini, Matteo, Peccatori, Fedro A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315728/
https://www.ncbi.nlm.nih.gov/pubmed/35884518
http://dx.doi.org/10.3390/cancers14143457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315728/
https://www.ncbi.nlm.nih.gov/pubmed/35884518
http://dx.doi.org/10.3390/cancers14143457

Ejemplares similares